2-[(9R)-13-bromo-9-tricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaenyl]ethanol;methyl 4-methylbenzenesulfinate
C25H27BrO3S — CID 143151844
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(9R)-13-bromo-9-tricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaenyl]ethanol;methyl 4-methylbenzenesulfinate
2-[(9R)-13-bromo-9-tricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaenyl]ethanol;methyl 4-methylbenzenesulfinate (PubChem CID 143151844) has the molecular formula C25H27BrO3S and a molecular weight of 487.46 g/mol. Its IUPAC name is 2-[(9R)-13-bromo-9-tricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaenyl]ethanol;methyl 4-methylbenzenesulfinate.
Molecular Properties
| Compound Name | 2-[(9R)-13-bromo-9-tricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaenyl]ethanol;methyl 4-methylbenzenesulfinate |
|---|---|
| PubChem CID | 143151844 |
| Molecular Formula | C25H27BrO3S |
| Molecular Weight | 487.46 g/mol |
| Exact Mass | 486.09 |
| IUPAC Name | 2-[(9R)-13-bromo-9-tricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaenyl]ethanol;methyl 4-methylbenzenesulfinate |
| SMILES | COS(=O)c1ccc(C)cc1.OCC[C@H]1Cc2cc(Br)ccc2Cc2ccccc21 |
| InChI | InChI=1S/C17H17BrO.C8H10O2S/c18-16-6-5-12-9-13-3-1-2-4-17(13)14(7-8-19)10-15(12)11-16;1-7-3-5-8(6-4-7)11(9)10-2/h1-6,11,14,19H,7-10H2;3-6H,1-2H3/t14-;/m0./s1 |
| InChIKey | KCJMVAFBZJPINO-UQKRIMTDSA-N |
| XLogP | 5.73 |
| TPSA | 46.53 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 487.46 |
| LogP ≤ 5 | 5.73 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143151844 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.